Genzyme Patient Assistance Programs

Through a partnership with Genzyme Corporation, Renvela® and all formulations of Hectorol®  are available to financially qualified dialysis patients who have no prescription drug coverage. Eligible patients may receive up to a four-month supply and if necessary, may reapply at the end of their grant period.
 
The American Kidney Fund administers Genzyme’s Renal Patient Assistance Programs.  Assistance is made possible by a generous product donation from Genzyme.

One application allows you to apply for Renvela® or Hectorol®  Product. Applications are accepted on a rolling basis, throughout the year.

Download the Application and Instructions

Genzyme Renal Patient Assistance Program Application for 2012

Genzyme Renal Patient Assistance Program Application Instructions